Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the whitehall II cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 619-625

  Hackett, Ruth A ^a   Kivimäki, Mika ^a   Kumari, Meena ^b   Steptoe, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCORTISONE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CIRCADIAN RHYTHM; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE RELEASE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA LEVEL; AGED; ALGORITHM; BLOOD; CHEMISTRY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; SALIVA; UNITED KINGDOM;

AGED; ALGORITHMS; BLOOD GLUCOSE; CIRCADIAN RHYTHM; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SALIVA; UNITED KINGDOM;

EID: 84959378662     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2853     Document Type: Article

References (40)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64-S71.
2. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221.
3. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SRK, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222.
4. Morris DH, Khunti K, Achana F, et al. Progression rates from HbA1c 6. 0-6. 4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia. 2013;56(7):1489-1493.
5. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379(9833):2279-2290.
6. Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab. 2011;96(3):632-642.
7. Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens. 1987;5(4):425-433.
8. Phillips DI, Barker DJ, Fall CH, et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab. 1998;83(3):757-760.
9. Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol.-Endocrinol Metab. 2008; 295(2):E385-E392.
10. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet. 2006;367(9522):1605-1617.
11. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469-474.
12. Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34(10): 1423-1436.
13. Hackett RA, Steptoe A, Kumari M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J Clin Endocrinol Metab. 2014:jc. 2014-2459.
14. Lederbogen F, Hummel J, Fademrecht C, et al. Flattened circadian cortisol rhythm in type 2 diabetes. Exp Clin Endocrinol Amp Diabetes. 2011;119(09):573-575.
15. Champaneri S, Xu X, Carnethon MR, et al. diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism. 2012;61(7): 986-995.
16. Bruehl H, Wolf OT, Convit A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology. 2009;34(6):815-821.
17. Vreeburg SA, Kruijtzer BP, van Pelt J, et al. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology. 2009;34(8):1109-1120.
18. Schoorlemmer RMM, Peeters GMEE, van Schoor NM, Lips P. Relationships between cortisol level, mortality and chronic diseases in older persons. Clin. Endocrinol. 2009; 71(6):779-786.
19. Cooper GR. Methods for determining the amount of glucose in blood. CRC Crit Rev Clin Lab Sci. 1973;4(2):101-145.
20. Astles JR, Sedor FA, Toffaletti JG. Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific. Clin Biochem. 1996;29(1):27-31.
21. Joint Formulary Committee. British National Formulary. Pharmaceutical Press; 2013.
22. Kudielka BM, Broderick JE, Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom. Med. 2003; 65(2):313-319.
23. Kumari M, Shipley M, Stafford M, Kivimaki M. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II Study. J Clin Endocrinol Metab. 2011;96(5):1478-1485.
24. Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II Study. J Clin Endocrinol Metab. 2010; 95(9):4415-4423.
25. Di Dalmazi G, Pagotto U, Pasquali R, Vicennati V. glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab. 2012;2012(525093):1-9.
26. Pankow JS, Duncan BB, Schmidt MI, et al; Atherosclerosis Risk in Communities Study. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2004;27(1):77-82.
27. Silva NMGD, Freathy RM, Palmer TM, et al. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes. 2011;60(3):1008-1018.
28. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMCPublic Health. 2009;9(1):88.
29. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116(11):1234-1241.
30. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001; 294(5549):2166-2170.
31. Walker BR, Andrew R. Tissue production of cortisol by 11-hydroxysteroid dehydrogenase type 1 and metabolic disease. AnnNY Acad Sci. 2006;1083(1):165-184.
32. Rosenstock J, Banarer S, Fonseca VA, et al; Investigators for the I-202 P. The 11-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care. 2010;33(7):1516-1522.
33. Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes. Diabetes Care. 2013;36(1):166-175.
34. Arjona A, Sarkar DK. Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells. Neurochem Res. 2008;33(4):708-718.
35. Buxton OM, Cain SW, O'Connor SP, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4(129):129ra43-129ra43.
36. Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010;9(45): 112-118.
37. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 2007;133(1):25-45.
38. Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT. Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci. 2006;103(45):17058-17063.
39. Hellhammer J, Fries E, Schweisthal OW, Schlotz W, Stone AA, Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state and trait components. Psychoneuroendocrinology. 2007;32(1):80-86.
40. Dockray S, Bhattacharyya MR, Molloy GJ, Steptoe A. The cortisol awakening response in relation to objective and subjective measures of waking in the morning. Psychoneuroendocrinology. 2008;33(1): 77-82.